deoxycytidine has been researched along with Hearing Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babacan, NA; Doğan, M; Kaçan, T; Kiliçkap, S; Koç, S; Seker, MM; Uysal, IO; Yüce, S | 1 |
| Baas, P; Beijnen, JH; Crul, M; Rademaker-Lakhai, JM; Schellens, JH; Simis, YJ; van Zandwijk, N; Zuur, L | 1 |
1 trial(s) available for deoxycytidine and Hearing Loss
| Article | Year |
|---|---|
Oxaliplatin and ototoxicity: is it really safe for hearing?
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cohort Studies; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Hearing Loss; Hearing Tests; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms | 2014 |
1 other study(ies) available for deoxycytidine and Hearing Loss
| Article | Year |
|---|---|
Relationship between cisplatin administration and the development of ototoxicity.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Audiometry; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Hearing; Hearing Loss; Hearing Loss, High-Frequency; Humans; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic | 2006 |